US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 883.200
  • -7.480-0.84%
Close Apr 26 16:00 ET
  • 881.210
  • -1.990-0.23%
Post 16:36 ET
97.32BMarket Cap25.40P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Regeneron Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 2, 2024

Revenue(YoY)

3.22B

+1.89%
EPS(YoY)

7.91

+10.32%

Buy

Apr 28, 2024

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 3.408B--
May 2, 20242024/Q1-- / 3.222B--
Feb 2, 20242023/Q43.434B / 3.287B--
Nov 2, 20232023/Q33.363B / 3.222B--
Aug 3, 20232023/Q23.158B / 3.025B--
May 4, 20232023/Q13.162B / 2.998B--
--2022/Q43.414B / 3.113B--
Nov 3, 20222022/Q32.936B / 2.870B--
Aug 3, 20222022/Q22.857B / 2.797B--
May 4, 20222022/Q12.965B / 2.690B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 3.408B--
May 2, 20242024/Q1-- / 3.222B--
Feb 2, 20242023/Q43.434B / 3.287B--
Nov 2, 20232023/Q33.363B / 3.222B--
Aug 3, 20232023/Q23.158B / 3.025B--
May 4, 20232023/Q13.162B / 2.998B--
--2022/Q43.414B / 3.113B--
Nov 3, 20222022/Q32.936B / 2.870B--
Aug 3, 20222022/Q22.857B / 2.797B--
May 4, 20222022/Q12.965B / 2.690B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 28, 2024

Buy

  • Buy

    77.27%
  • Hold

    18.18%
  • Sell

    4.55%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg